Navigation Links
Pharmaceutical Innovation Spotlighted at ISPE Annual Meeting
Date:11/8/2012

TAMPA, Fla., Nov. 8, 2012 /PRNewswire-USNewswire/ -- The pharmaceutical industry's contributions to global public health will be spotlighted at the 2012 ISPE Annual Meeting in San Francisco, 11-14 November 2012. From nearly halving the rate of recurrence or death from breast cancer to extending the lives of patients diagnosed with HIV/AIDS, pharmaceutical drugs have had a tremendous positive impact on a global scale.

(Photo: http://photos.prnewswire.com/prnh/20121108/DC08417)

(Logo: http://photos.prnewswire.com/prnh/20120912/DC73253LOGO)

"The pharmaceutical industry bears great responsibility for producing safe medicines that lengthen life expectancy and improve quality of life for patients around the world every day," said ISPE President and CEO Nancy Berg. "The 20,000 pharmaceutical professionals who belong to ISPE dedicate their professional lives and countless hours of personal time working to improve development, production quality and distribution processes so that patients have life-saving medications that are reliably available and safe."

Here are just some examples of improvements the pharmaceutical industry has made in the welfare of patients:

  • Medicines and treatments contributed to a 45% decline in deaths from heart attack and heart disease.
  • The survival rate for patients suffering from leukemia has quadrupled in the past 49 years, due to the development of new medications and the discovery of new uses for existing medications.
  • The rate of cancer deaths has dramatically declined, with one major study reporting that new medicines account for 50-60% of survival increases.
  • The survival rate of children with cancer has increased 40% since 1975.
  • Since the introduction of highly active antiretroviral treatments (HAART) in 1995, the death rate from AIDS has plummeted from 16.2 per 100,000 to just 2.7 in 2010.
  • Combination drug therapy can eliminate Hepatitis C in up to five out of 10 persons with the most common genotype in the U.S.
  • Multiple Sclerosis patients depend on numerous FDA-approved medications to improve their quality of life, and in some cases, slow the underlying course of the disease.

Pharmaceutical companies produce medicines that have revolutionized the fight against disease and saved or improved lives everywhere. New medicines are helping patients live longer and healthier lives. The 2012 ISPE Annual Meeting will bring together pharmaceutical professionals and regulatory authorities from around the world for strategic discussions that will allow the industry to continue to improve public health in more efficient and effective ways.

For more information on ISPE's Annual Meeting, please visit www.ISPE.org/2012AnnualMeeting.

About ISPE
ISPE, the International Society for Pharmaceutical Engineering is the world's largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit www.ISPE.org for more information.

For more information contact:
Danielle Hould
ISPE Communications Manager
Tel: +1-813-960-2105, ext. 277
email: dhould@ispe.org
www.ISPE.org  


'/>"/>
SOURCE ISPE
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
Breaking Medicine Technology:
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):